Novonesis (formerly Chr. Hansen)
Novonesis is a Danish biosolutions company formed from the January 2024 merger of Chr. Hansen (founded 1874) and Novozymes. Headquartered in Hoersholm, Denmark, the combined company has approximately 10,000 employees worldwide and EUR 3.7 billion in annual revenue. The health and nutrition division supplies probiotic cultures, bacterial strains, enzymes, and human milk oligosaccharides (HMOs) to the global dietary supplement and food industries. Chr. Hansen's 150-year legacy in bacterial cultures makes Novonesis one of the world's largest culture collections for probiotic applications. The company operates US production facilities for probiotics.
Hoersholm, Denmark
Directory Listing · Records Reviewed
Public records and independent sources have been reviewed.
What this means →- MOQMOQ (Minimum Order Quantity)The smallest production run a manufacturer will accept for an order.
- Not publicly disclosed
- LEAD TIMELead TimeThe time from order placement to finished product delivery.
- Not publicly disclosed
§1Editorial assessment
Novonesis is a Danish biosolutions company formed from the January 2024 merger of Chr. Hansen (founded 1874) and Novozymes. Headquartered in Hoersholm, Denmark, the combined company has approximately 10,000 employees worldwide and EUR 3.7 billion in annual revenue. The health and nutrition division supplies probiotic cultures, bacterial strains, enzymes, and human milk oligosaccharides (HMOs) to the global dietary supplement and food industries. Chr. Hansen's 150-year legacy in bacterial cultures makes Novonesis one of the world's largest culture collections for probiotic applications. The company operates US production facilities for probiotics.
§2Our review
The six checks in our review, applied before any name appears in the directory. Each check is auto-derived from public evidence on this profile.
§3Inspection history
§4Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
§5Capability matrix
- PRODUCT TYPES
- Probiotic Cultures & Strains · Bacterial Cultures · Enzymes · Human Milk Oligosaccharides (HMOs)
- CAPABILITIES
- Probiotic Strain Development & Manufacturing · World's Largest Microbial Culture Collection · Clinical Research Programs · US Production Facilities · Enzyme Production · HMO Manufacturing
§6Sources
Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.
What We Couldn't Verify
- Headquarters in Denmark; additional manufacturing in multiple countries including US
- Company underwent major merger (Chr. Hansen + Novozymes) in January 2024. Integration still in progress
- Very large conglomerate (EUR 3.7B revenue). Dietary supplement ingredients are one division among many
- Certification details beyond cGMP not independently verified from public databases
Last reviewed: April 2, 2026
Disclosures
- No material connection exists between Inventory Ready and this company
For the check-by-check breakdown that produces this vendor's score, see our scoring framework. The connection map between Novonesis (formerly Chr. Hansen) and other vendors, capabilities, and certifications is in the manufacturer atlas.
Our Evaluation Method
Every manufacturer assessment follows six principles:
- Evidence: Claims backed by documentation, not marketing copy
- Freshness: Information reviewed and dated within the last 12 months
- Provenance: Sources cited for every key claim
- Challenge: Inconsistencies flagged, not hidden
- Disclosure: Material connections stated directly on affected listings
- Abstention: When we can't assess, we say so explicitly
Interested in Novonesis (formerly Chr. Hansen)?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.